Prestige Consumer Healthcare
PBH
#4654
Rank
NZ$4.07 B
Marketcap
NZ$85.94
Share price
0.75%
Change (1 day)
-19.37%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2026 (TTM): NZ$6.23

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is NZ$6.40. In 2025 the company made an earnings per share (EPS) of NZ$6.79 a decrease over its 2024 EPS that were of NZ$7.66.

EPS history for Prestige Consumer Healthcare from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$6.23-8.22%
2025NZ$6.79-11.4%
2024NZ$7.66-367.08%
2023NZ-$2.87-138.33%
2022NZ$7.4811.7%
2021NZ$6.7013.6%
2020NZ$5.90-651.67%
2019NZ-$1.07-148.78%
2018NZ$2.19-83.29%
2017NZ$13.11437.23%
2016NZ$2.44-34.13%
2015NZ$3.7152.94%
2014NZ$2.42-8.11%
2013NZ$2.64
2011NZ$1.55

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.56 143.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
NZ$12.05 88.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$11.87 85.52%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.35-78.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$5.56-13.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
NZ$11.01 72.14%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
NZ$4.12-35.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.70-10.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
NZ-$52.78-925.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
NZ$2.17-66.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel